Results 71 to 80 of about 825,494 (348)

Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer [PDF]

, 2008
Objective: To validate the prognostic value of preoperative levels of CYFRA 21-1, CEA and the corresponding tumor marker index (TMI) in patients with stage I non-small cell lung cancer (NSCLC). Methods: Two hundred forty stage I NSCLC patients (80 in pT1
Ankerst, Donna Pauler, Blankenburg, Florian, Gruber, Christine, Hatz, Rudolf, Nagel, Dorothea, Reinmiedl, Judith, Seidel, Dietrich, Stieber, Petra   +7 more
core   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Non-small cell lung carcinoma in an adolescent manifested by acute paraplegia due to spinal metastases: a case report

Journal of Medical Case Reports, 2011
Introduction Bronchial carcinomas in childhood and adolescence are extremely rare; only individual cases have been reported previously. Case presentation We report on a 16-year-old Caucasian German boy with non-small cell lung carcinoma (squamous cell ...
Haffner Dieter, Ackert Ulrike, Classen Carl   +2 more
doaj   +1 more source

Life Threatening haemoptysis in primary lung cancer-signet ring cell carcinoma

Respiratory Medicine Case Reports, 2020
Primary signet ring cell carcinoma of the lung is a rare non-small cell carcinoma of the lung with extremely aggressive features and poor prognosis. The diagnosis mainly required tissue biopsy with immunohistochemical analysis and gene mutation studies ...
Shamsuddin Anwar, Sudeep Acharya, Dany Elsayegh, Alisa Sokoloff, Maryam Rehan   +4 more
doaj   +1 more source

Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma

Journal of Extracellular Vesicles, 2015
Background Lung cancer is one of the leading causes of cancer-related death. At the time of diagnosis, more than half of the patients will have disseminated disease and, yet, diagnosing can be challenging.
K. R. Jakobsen, B. S. Paulsen, Rikke Bæk, K. Varming, B. Sørensen, M. Jørgensen   +5 more
semanticscholar   +1 more source

Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes [PDF]

, 2012
Objective To evaluate the clinical outcome and safety of stereotactic ablative radiotherapy for medically inoperable stage I non- small-cell lung carcinoma. Design Retrospective case series.
Chan, Connie C C, Chan, Oscar S H, Chang, Amy T Y, Hung, Albert W M, Lee, Anne W M, Lee, Michael C H, Yeung, Rebecca M W   +6 more
core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene

Chinese Journal of Lung Cancer, 2022
Anaplastic lymphoma kinase (ALK) fusion gene is an important tumor driver gene of non-small cell lung cancer, accounting for about 5% of patients with non-small cell lung cancer, of which 97% are patients with lung adenocarcinoma.
Yue YUAN, Zheng WANG, Xin NIE, Ping ZHANG, Lin LI   +4 more
doaj   +1 more source

Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma [PDF]

Journal of Cancer Research Updates, 2013
Lung cancer is the most commonly diagnosed cancer in the world. “Driver” and “passenger” mutations identified in lung cancer indicate that genetics play a major role in the development of the disease, progression, metastasis and response to therapy.
Wangari-Talbot, Janet, Hopper-Borge, Elizabeth   +1 more
openaire   +2 more sources

Arsenic trioxide suppresses tumour growth in squamous cell lung carcinoma [PDF]

, 2015
This journal suppl. entitled: 20th Medical Research Conference; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong KongINTRODUCTION: Squamous cell lung carcinoma (SCC) belongs to the second most common subtype in non–small ...
Ho, JCM, Lam, SK, Leung, LL
core